Insmed Inc (INSM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 606,423 | 363,707 | 305,208 | 245,358 | 188,461 |
| Cost of Goods | 122,938 | 85,742 | 65,573 | 55,126 | 44,152 |
| Gross Profit | 483,485 | 277,965 | 239,635 | 190,232 | 144,309 |
| Operating Expenses | 1,731,192 | 1,156,959 | 949,834 | 647,679 | 519,555 |
| Operating Income | -1,246,769 | -878,252 | -709,626 | -457,321 | -375,094 |
| Interest Expense | 83,795 | 84,913 | 81,694 | 26,446 | 40,473 |
| Other Income | 58,815 | 53,100 | 44,308 | 3,616 | -20,845 |
| Pre-tax Income | -1,271,749 | -910,065 | -747,012 | -480,151 | -436,412 |
| Income Tax | 5,026 | 3,707 | 2,555 | 1,383 | -1,758 |
| Net Income Continuous | -1,276,775 | -913,772 | -749,567 | -481,534 | -434,654 |
| Net Income | $-1,276,775 | $-913,772 | $-749,567 | $-481,534 | $-434,654 |
| EPS Basic Total Ops | -6.42 | -5.57 | -5.34 | -3.91 | -3.88 |
| EPS Basic Continuous Ops | -6.42 | -5.57 | -5.34 | -3.91 | -3.88 |
| EPS Diluted Total Ops | -6.42 | -5.57 | -5.34 | -3.91 | -3.88 |
| EPS Diluted Continuous Ops | -6.42 | -5.57 | -5.34 | -3.91 | -3.88 |
| EPS Diluted Before Non-Recurring Items | -6.42 | -5.57 | -5.34 | -3.90 | -3.75 |
| EBITDA(a) | $-1,221,391 | $-857,643 | $-689,015 | $-441,039 | $-328,795 |